Skip to main content

Ohio State first in central Ohio to use novel heart failure therapy

By
Ohio State University Wexner Medical Center, Press Release

More than 6 million Americans live with heart failure, and about half have an enlarged left ventricle, which causes stress on the heart and less blood pumped with each heartbeat. The Ohio State University Wexner Medical Center is the first in central Ohio to take part in a global clinical trial to use a novel therapy to reduce the size of the left ventricle without open-heart surgery.
 
“Certain patients with heart failure from reduced left ventricular ejection function can remain symptomatic despite optimal medical management. Patients may experience trouble breathing and fatigue, and at times require hospitalization. This novel therapy is designed to improve the structure and function of the heart and provide relief for patients who continue to have symptoms,” said Konstantinos Dean Boudoulas, MD, an interventional cardiologist and principal investigator of the CORCINCH-HF trial at Ohio State.
 
Boudoulas performed the first procedure on Jan. 31 along with Scott Lilly, MD, interventional cardiologist, and Thura Harfi, MD, a cardiologist specializing in imaging. The patient was a 48-year-old Columbus man with congestive heart failure and persistent symptoms despite medical therapy. 
 
During the minimally invasive procedure, the doctors threaded a catheter from the groin to the heart. They attached an implant to the inner wall of the left ventricle and cinched it to reduce the size of the left ventricle and strengthen the heart wall. 
 
Two years ago, the FDA granted breakthrough device designation for the AccuCinch ventricular restoration system to expedite device access for life-threatening and debilitating diseases.
 
“We are fortunate to be in a position to participate in this pivotal trial, as well as a variety of other novel clinical trials, evaluating groundbreaking therapies,” Boudoulas said.

More information about the phase 3 safety and efficacy study can be found at clinicaltrials.gov.
 
Publisher's note: A free press is critical to having well-informed voters and citizens. While some news organizations opt for paid websites or costly paywalls, The Highland County Press has maintained a free newspaper and website for the last 25 years for our community. If you would like to contribute to this service, it would be greatly appreciated. Donations may be made to: The Highland County Press, P.O. Box 849, Hillsboro, Ohio 45133. Please include "for website" on the memo line.